Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-15-026693
Filing Date
2015-04-30
Accepted
2015-04-30 17:29:14
Documents
6
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A v408719_10ka.htm 10-K/A 816839
2 EXHIBIT 3.1 v408719_exh3x1.htm EX-3.1 51949
3 EXHIBIT 31.3 v408719_exh31x3.htm EX-31.3 5190
4 EXHIBIT 31.4 v408719_exh31x4.htm EX-31.4 5171
5 GRAPHIC line.gif GRAPHIC 43
6 GRAPHIC spacer.gif GRAPHIC 43
  Complete submission text file 0001144204-15-026693.txt   880561
Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35668 | Film No.: 15820580
SIC: 2834 Pharmaceutical Preparations